Fig. 1.
Cells expressing GpIb are selected against during routine passage. Expression of GpIb (reported by flow cytometry fluorescence with FITC-conjugated anti-GpIb antibody AN51) was identified immediately after antibiotic and immunomagnetic bead selection (passage 1), but this decreased progressively with each cell passage to the point that, after the tenth passage, no expression was detectable (passage 10).